PLENARY SESSION PRESENTATIONS

1. Historical Pitfalls
   by Prof. Per Kjaersgaard-Andersen | PDF | 27 pages | 2.7Mb
2. Safety Challenges in Arthroplasty: Surgeon’s Views
   by Prof. Li Felländer-Tsai | PDF | 30 pages | 3.1Mb
3. Safety Challenges in Arthroplasty: Patient’s Views
   by Mr. Dieter Wiek | PDF | 15 pages | 0.5Mb
4. Safety Challenges in Arthroplasty: Manufacturer’s Views
   by Mrs. Katharina von Strünsee | PDF | 14 pages | 0.7Mb
5. Need for Innovation
   by Prof. Francesco Benazzo | PDF | 31 pages | 6.6Mb
6. Surveillance and Vigilance
   by Dr. Matthias Fink & Dr. Bassil Akra | PDF | 11 pages | 1Mb
7. The Role of Clinicians under the new MDR
   by Mr. Paul Piscoi | PDF | 27 pages | 1.1Mb
8. Surveillance and Vigilance: Manufacturer’s Contribution
   by Mr. Hassan Achakri | PDF | 9 pages | 0.3Mb
9. Surveillance and Vigilance: Surgeon’s Contribution
   by Prof. Rob Nelissen | PDF | 31 pages | 5.6Mb
10. Failure Analysis – Practice and Future Challenges
    by Prof. Michael Morlock | PDF | 13 pages | 2Mb

 

SYMPOSIUM PRESENTATIONS

• NIMAC Symposium Programme | PDF document, 4 pages, 189kb
• Welcome and Introduction | PDF document, 15 pages, 873kb
• Where we stand in EFORT | PDF document, 9 pages, 451kb
• The Life of a TJR The stages of regulating and monitoring a total joint replacement: Now and the future | PDF document, 26 pages, 235kb
• Medical Device Regulation & Registries | PDF document, 26 pages, 586kb
• Impact on Industry of the New Medical Device Regulation (MDR) | PDF document, 8 pages, 429kb
• Certification of JRIs under the MDR | PDF document, 24 pages, 261kb
• Scientific Evidence and Innovation in the EU | PDF document, 38 pages, 4.5Mb
• Shifting paradigms for high-risk devices: lessons learned from the past | PDF document, 10 pages, 857kb
• Engaging with the new EU Regulatory Landscape for medical devices – Clinical Evidence for Medical Devices | PDF document, 13 pages, 1.6Mb
• Minimum Requirements, Clinical practice and Lessons learnt from the past | PDF document, 49 pages, 3Mb
• Monitoring by registries or do we still need clinical trials? The Pros and Cons | PDF document, 38 pages, 5.6Mb
• Postmarket surveillance & (Quality) Registries | PDF document, 24 pages, 2.2Mb
• Engaging with the new EU regulatory landscape for medical device – Challenges and opportunities | PDF document, 17 pages, 580kb
• The new EU MDR – lessons learned from the past | PDF document, 6 pages, 411kb